ArticleScientific reports2026
Circulating type I collagen pro-α1 chain is inversely associated with the presence of coronary atherosclerosis in a Swedish middle-aged population.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The turnover of type I collagen plays an important role in atherogenesis and atherothrombosis. The pro-α1(I) chain of type I collagen (COL1α1) has emerged as a novel circulating biomarker associated with coronary artery disease (CAD) events. This study aimed to investigate the association between circulating COL1α1 and coronary atherosclerosis in a middle-aged general population. Participants (n = 1 078) were randomly recruited from the Linköping branch of the Swedish Cardiopulmonary Bioimage Study (SCAPIS) comprising an equal number of men and women 50–64 years old. Coronary artery calcium scores were calculated from non-contrast computed tomography (CT) while coronary stenosis, presence of plaques and segmental involvement scores were derived from coronary CT angiography. COL1α1, interleukin-6 and matrix metalloproteinase-9 were quantified in plasma. Binary logistic regression models were used. Participants with low COL1α1 levels exhibited a more unfavorable cardiovascular risk profile. There was an inverse association between COL1α1 and all measures of coronary atherosclerosis before adjustment (ORrange=0.50–0.73, p < 0.05 for all). In two multivariable models adjusting for potential confounders and CAD risk factors, an association with coronary stenosis ≥ 50% (OR = 0.61 and 0.59, respectively) and non-calcified atherosclerotic plaques (OR = 0.62 for both) remained (p < 0.05 for all). The findings shed further light on COL1α1 as a potential CAD biomarker.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.